Is there a standard-of-care for transfusion therapy in thalassemia?

Massimo Franchini, Gian L. Forni, Giancarlo M. Liumbruno

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Purpose of review Thalassemia is the most common form of inherited anemia, characterized by variable clinical phenotypes. The purpose of this review is to summarize the transfusion support in thalassemia patients and the management of transfusion-related iron overload. Recent findings The most recent evidence on transfusion strategy and iron chelation therapy in thalassemia arising from clinical trials as well as from recommendation guidelines are critically discussed. Summary Enhancements in the global care of thalassemia, resulting from the combination of an appropriate transfusion approach and iron chelation therapy, have produced a significant improvement in the quality of life and, finally, in the prognosis of patients affected by this inherited hematologic disorder.

Original languageEnglish
Pages (from-to)558-564
Number of pages7
JournalCurrent Opinion in Hematology
Volume24
Issue number6
DOIs
Publication statusPublished - Nov 1 2017

Fingerprint

Thalassemia
Standard of Care
Chelation Therapy
Iron
Iron Overload
Therapeutics
Anemia
Quality of Life
Clinical Trials
Guidelines
Phenotype

Keywords

  • iron chelation
  • iron overload
  • red blood cell transfusion
  • thalassemia

ASJC Scopus subject areas

  • Hematology

Cite this

Is there a standard-of-care for transfusion therapy in thalassemia? / Franchini, Massimo; Forni, Gian L.; Liumbruno, Giancarlo M.

In: Current Opinion in Hematology, Vol. 24, No. 6, 01.11.2017, p. 558-564.

Research output: Contribution to journalReview article

@article{a718a1dc091541d28082dbe5f1b46d52,
title = "Is there a standard-of-care for transfusion therapy in thalassemia?",
abstract = "Purpose of review Thalassemia is the most common form of inherited anemia, characterized by variable clinical phenotypes. The purpose of this review is to summarize the transfusion support in thalassemia patients and the management of transfusion-related iron overload. Recent findings The most recent evidence on transfusion strategy and iron chelation therapy in thalassemia arising from clinical trials as well as from recommendation guidelines are critically discussed. Summary Enhancements in the global care of thalassemia, resulting from the combination of an appropriate transfusion approach and iron chelation therapy, have produced a significant improvement in the quality of life and, finally, in the prognosis of patients affected by this inherited hematologic disorder.",
keywords = "iron chelation, iron overload, red blood cell transfusion, thalassemia",
author = "Massimo Franchini and Forni, {Gian L.} and Liumbruno, {Giancarlo M.}",
year = "2017",
month = "11",
day = "1",
doi = "10.1097/MOH.0000000000000373",
language = "English",
volume = "24",
pages = "558--564",
journal = "Current Opinion in Hematology",
issn = "1065-6251",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Is there a standard-of-care for transfusion therapy in thalassemia?

AU - Franchini, Massimo

AU - Forni, Gian L.

AU - Liumbruno, Giancarlo M.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Purpose of review Thalassemia is the most common form of inherited anemia, characterized by variable clinical phenotypes. The purpose of this review is to summarize the transfusion support in thalassemia patients and the management of transfusion-related iron overload. Recent findings The most recent evidence on transfusion strategy and iron chelation therapy in thalassemia arising from clinical trials as well as from recommendation guidelines are critically discussed. Summary Enhancements in the global care of thalassemia, resulting from the combination of an appropriate transfusion approach and iron chelation therapy, have produced a significant improvement in the quality of life and, finally, in the prognosis of patients affected by this inherited hematologic disorder.

AB - Purpose of review Thalassemia is the most common form of inherited anemia, characterized by variable clinical phenotypes. The purpose of this review is to summarize the transfusion support in thalassemia patients and the management of transfusion-related iron overload. Recent findings The most recent evidence on transfusion strategy and iron chelation therapy in thalassemia arising from clinical trials as well as from recommendation guidelines are critically discussed. Summary Enhancements in the global care of thalassemia, resulting from the combination of an appropriate transfusion approach and iron chelation therapy, have produced a significant improvement in the quality of life and, finally, in the prognosis of patients affected by this inherited hematologic disorder.

KW - iron chelation

KW - iron overload

KW - red blood cell transfusion

KW - thalassemia

UR - http://www.scopus.com/inward/record.url?scp=85024487784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024487784&partnerID=8YFLogxK

U2 - 10.1097/MOH.0000000000000373

DO - 10.1097/MOH.0000000000000373

M3 - Review article

C2 - 28719386

AN - SCOPUS:85024487784

VL - 24

SP - 558

EP - 564

JO - Current Opinion in Hematology

JF - Current Opinion in Hematology

SN - 1065-6251

IS - 6

ER -